Token Launch definition

Token Launch means the bona fide issuance of the Tokens to Purchaser that is compliant with the ERC-20 standard (or any other standard that the Company may elect in its sole discretion).
Token Launch means a bona fide issuance of Tokens to the general public in a publicized product launch and provided that the satisfaction of this clause shall be determined by the Company in its sole discretion.
Token Launch means a bona fide transaction or series of transactions, pursuant to which the Company will sell the Tokens to the general public in a publicized product launch.

Examples of Token Launch in a sentence

  • Upon the Token Launch, the Preferred Stock associated with the Tokens will have the rights, powers and preferences, and restrictions and limitations thereon, described in the Offering Memorandum Token Terms and Conditions, which will be set forth in an amendment to the Company’s Certificate of Incorporation.

  • ETH contributions shall be sent to the Ethereum wallet address specified on the Token Launch website.

  • Sec- ondly, the project could consider Token Launch as an alternative to Counterparty proto- col.

  • AJEET KHURANATechnology and Token Launch Advisor for SPORTZCHAINEx-CXO of Zebpay and Head of Blockchain & Crypto Committee (India).

  • USD value may fluctuate during the Token Launch which results in different ratios between USD and ALICE tokens, but never in any change in ETH.Remaining Coins If our hard cap is not reached during the Token Launch, the remaining ALICE tokens will be allocated to the Incentive Pool, further driving the growth of Leap With Alice.

  • For instance, Venture Capital and ICO or Crowdfunding and Token Launch.

  • Kuva ubwo, rubanda rwatangiye kumubona nk’umuntu usanzwe, aho kumubonamo ububasha bukomoka ku Mana.

  • These terms and conditions (hereinafter the “Terms”), and any terms and conditions published from time to time on the Website (being xxx.xxxxxxxxx.xx), Token Launch Dashboard, all subdomains and all their respective pages constitute the legal relationship and agreement between you, and Skyfdrones Services OU with the address Tööstuse 00x-000, Xxxxxxxxxxx, Xxxxxxxxxxx, Xxxxxxx (“Company”) in respect of your participation in the Token Launch, receiving and holding Tokens, and your use of the Website.

  • From Q2 2018 until Q1 2019, various rounds (Presale, Pre-ICO, and ICO) will make up the ALICE Token Launch.

  • In the worst-case scenario, Tokens could be rendered worthless.The Token Launch and the performance of the Company’s activities set out in this Whitepaper and the development roadmap may be interrupted, suspended or delayed due to force majeure circumstances.


More Definitions of Token Launch

Token Launch means a transaction or series of transactions, pursuant to which the Company will sell the Tokens to the public in a public product launch.

Related to Token Launch

  • Launch means the intentional ignition of the first-stage motor(s) of the Launch Vehicle intended to place or try to place a Launch Vehicle (which may or may not include any Transfer Vehicle, Payload or crew) from Earth:

  • Commercial Launch means the initial First Commercial Sale of a Product in the Territory.

  • Launch Date has the meaning specified therefor in Section 2.02(b) of this Agreement.

  • Launch Vehicle means an object, or any part thereof, intended for launch, launched from Earth, or returning to Earth which carries Payloads or persons, or both.

  • FDA Approval means the approval by the FDA of a premarket approval application to market and sell a Product, as evidenced by the publication of such approval by the FDA.

  • Marijuana product means marijuana as defined in 50-32-101 and marijuana-infused products

  • Marketing Authorization means all approvals from the relevant Regulatory Authority necessary to market and sell a Product in any country (including without limitation, all applicable pricing and governmental reimbursement approvals even if not legally required to sell Product in a country).

  • Regulatory Approval means any approval or clearance by any governmental agency or agencies having authority to regulate the use or sale of any Licensed Product(s) in the pertinent jurisdiction or territory.

  • Medical marijuana product means a product that contains cannabinoids that have been extracted from plant material or the resin therefrom by physical or chemical means and is intended for administration to a licensed patient, including but not limited to concentrates, oils, tinctures, edibles, pills, topical forms, gels, creams, and other derivative forms, except that this term does not include live plant forms.

  • Tobacco product means any substance containing tobacco leaf, including but not limited to, cigarettes, cigars, pipe tobacco, hookah tobacco, snuff, chewing tobacco, dipping tobacco, bidis, blunts, clove cigarettes, or any other preparation of tobacco; and any product or formulation of matter containing biologically active amounts of nicotine that is manufactured, sold, offered for sale, or otherwise distributed with the expectation that the product or matter will be introduced into the human body by inhalation; but does not include any cessation product specifically approved by the U.S. Food and Drug Administration for use in treating nicotine or tobacco dependence.

  • Licensed System means, collectively:

  • Licensed Product means a product, method or service in the Licensed Field of Use, the making, having made, using, importing or selling of which, absent this license, infringes, induces infringement, or contributes to infringement of a Licensed Patent.

  • Phase I Clinical Study means a human clinical study of a product, the principal purpose of which is a preliminary determination of safety in healthy individuals or patients, as described in 21 C.F.R. 312.21(a).

  • Licensed Program means the executable processing programs of licensed information, which is composed of various modules in the Licensed Software package provided by the Licensor.

  • Phase III Clinical Trials means a Clinical Trial for the Product on sufficient numbers of patients to generate safety and efficacy data to support Regulatory Approval in the proposed therapeutic indication, conducted in accordance with current good clinical practices and in accordance with a protocol that has been reviewed by the FDA and reflects any comments or concerns raised by the same.

  • Approved clinical trial means a phase I, phase II, phase III, or phase IV clinical trial that is conducted in relation to the prevention, detection, or treatment of cancer or other life-threatening disease or Condition and is described in any of the following:

  • Phase III Clinical Study means a human clinical study of a product on a sufficient number of subjects that is designed to establish that such product is safe and efficacious for its intended use, and to determine warnings, precautions, and adverse reactions that are associated with such product in the dosage range to be prescribed, which trial is intended to support Regulatory Approval of such product, as described in 21 C.F.R. 312.21(c). 1.185. [***] 1.186. [***]

  • Commercial Sale means for a given product and country the sale for value of that product by a Party (or, as the case may be, by an Affiliate or permitted sublicensee of a Party), to a Third Party after regulatory approval (if necessary) has been obtained for such product in such country.

  • Final Product means a product that is not used in producing other products and is built and intended for use outdoors, provided the final product has not deteriorated or has otherwise become a potential source of contaminants.

  • Video programming means programming provided by, or generally considered comparable to programming provided by, a television broadcast station.

  • Phase 4 Clinical Trial means a Clinical Trial of a Product conducted after Regulatory Approval of such Product has been obtained from an appropriate Regulatory Authority, which trial is (a) conducted voluntarily by a Party to enhance marketing or scientific knowledge of the Product, or (b) conducted due to a request or requirement of a Regulatory Authority.

  • Phase 2 Clinical Trial means a human clinical trial of a product in any country that would satisfy the requirements of 21 C.F.R. 312.21(b) and is intended to explore a variety of doses, dose response, and duration of effect, and to generate initial evidence of clinical safety and activity in a target patient population, or a similar clinical study prescribed by the relevant Regulatory Authorities in a country other than the United States.

  • Hemp product means the same as that term is defined in § 3.2-4112.

  • XXXXX System means the XXXXX filing system of the Commission and the rules and regulations pertaining thereto promulgated by the Commission in Regulation S-T under the Securities Act and the Exchange Act, in each case as the same may be amended or succeeded from time to time (and without regard to format).

  • Marketing Authorization Application or “MAA” means an application for Regulatory Approval in a country, territory or possession.

  • Regulatory Approval Application means any application submitted to an appropriate Regulatory Authority seeking any Regulatory Approval.